![]() Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Overview page represent trading in all U.S. Indexes: Index quotes may be real-time or delayed as per exchange requirements refer to time stamps for information on any delays. Copyright © FactSet Research Systems Inc. Fundamental company data and analyst estimates provided by FactSet. International stock quotes are delayed as per exchange requirements. stock quotes reflect trades reported through Nasdaq only comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. McKinsey Consulted VA While Advising Opioid Makers to Target Agency for SalesĮndo International Files for Bankruptcy to Weather Opioid Lawsuits (PR) Endo Announces First Patient Enrolled in Registry of Dupuytren's ContractureĮndo Launches Dexlansoprazole Capsules, Generic Version of Dexilant®Įndo Launches Dexlansoprazole Capsules, Generic Version of Dexilant(R)Įndo Launches PREVDUO (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled SyringeĮndo Launches PREVDUO(TM) (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled SyringeĮndo Announces Publication of XIAFLEX(R) (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology(R)Įndo Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology® (PR) Endo Presents New Data at the American Podiatric Medical Association Annual MeetingĮndo Launches First Generic Version of Noxafil® (posaconazole) InjectionĮndo Launches First Generic Version of Noxafil(R) (posaconazole) InjectionĮndo Announces Approval of XCOPRI (cenobamate tablets) in CanadaĮndo Announces Approval of XCOPRI(TM) (cenobamate tablets) in CanadaĮndo Announces First Patient Enrolled in Registry of Dupuytren's Contracture Collaborate to Address Pitocin(R) (oxytocin injection, USP) ShortageĮndo Presents New Data at the American Podiatric Medical Association Annual Meeting Collaborate to Address Pitocin® (oxytocin injection, USP) ShortageĮndo and Premier, Inc. (PR) Endo Launches Bivalirudin Injection in Ready-to-Use VialsĮndo and Premier, Inc. (PR) Endo Announces First Patient Enrolled in Registry of Peyronie's DiseaseĮndo Announces First Patient Enrolled in Registry of Peyronie's DiseaseĮndo Launches Bivalirudin Injection in Ready-to-Use Vials News Endo International PLC ENDPQ Significant News Only
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |